Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From dailyworldfeed.com

Maldives ex-leader says Chinese projects akin to land grab

Jan 22, 2018

COLOMBO, Sri Lanka — The exiled former leader of the Maldives said Monday that this year's presidential election could be the last chance to extricate his country from increasing Chinese influence, which he described as a land grab in the guise of investments in island development. Mohamed Nasheed told reporters in Sri Lanka's capital that current President Yameen Abdul Gayoom has opened the doors to Chinese investment without any regard for procedure or transparency. "A large emerging power is busy buying up the Maldives," Nasheed said, referring to China. China is "buying up our lands, buying up our key infrastructure...

Maldives ex-leader claims Chinese land grabbing; government denies

Jan 22, 2018

COLOMBO (Reuters) - Exiled former Maldives President Mohamed Nasheed, who is fighting for the right to contest a presidential poll this year, said on Monday that land grabbing by China was threatening peace and stability in the Indian Ocean. However, the administration of President Abdulla Yameen said Nasheed, who has been in exile on medical grounds from a 13-year jail sentence, should name the islands grabbed by China if he knew of any land grabbing.The island nation has been mired in political unrest since its first democratically elected leader Nasheed was ousted in 2012. He was later sentenced to 13...

India, Pakistan continue trading fire and blame in Kashmir

Jan 22, 2018

SRINAGAR, India — Indian and Pakistani soldiers again targeted each other's posts and villages along their volatile frontier in disputed Kashmir after a day's lull, killing at least one civilian and wounding three others, officials said Monday. Fighting erupted overnight as the rivals traded gunfire and shelling until dawn Monday, leaving a civilian dead and three others injured on the Indian side. The two sides resumed intermittent fighting at several places later Monday, officials said. The recent flare-up has left 13 civilians and nine soldiers dead and dozens injured on the two sides. The fighting also has caused extensive damage...

Bangladesh says start of Rohingya return to Myanmar delayed

Jan 22, 2018

By Zeba SiddiquiPALONG KHALI, Bangladesh (Reuters) - Bangladesh has delayed the repatriation of Rohingya Muslim refugees to Myanmar, set to start on Tuesday, because the process of compiling and verifying the list of people to be sent back is incomplete, a senior Bangladesh official said. The decision comes as tensions have risen in camps holding hundreds of thousands of refugees, some of whom are opposing their transfer back to Myanmar because of what they say is a lack of security guarantees.Myanmar and Bangladesh agreed earlier this month to complete the voluntary repatriation of the refugees within two years, starting on...

Two Indian states urge top court to permit ban on screening of controversial film

Jan 22, 2018

NEW DELHI (Reuters) - India's Supreme Court will hear an appeal on Tuesday against a controversial Bollywood film, for the second time in as many weeks, as two states seek to re-impose a ban on the movie, based on an epic poem about a 14th-century queen.The film "Padmaavat" ran into trouble after groups critical of the project accused its director, Sanjay Leela Bhansali, of distorting history by portraying a Muslim ruler as the "lover" of Queen Padmavati of the Hindu Rajput warrior clan.Monday's action comes after the Supreme Court last week cleared the way for the film's release and blocked...

About Us

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Contact us: sales@dailyworldfeed.com

Subscribe Now!